Clinical Trial Update: Compassionate Use Protocol for PF-03084014 in Patients With Advanced Solid Tumor Malignancies

View source ↗

Summary

This update notes that the compassionate-use protocol for PF-03084014 in patients with advanced solid tumors, including desmoid tumors, is no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Desmoid-type Fibromatosis

Drugs mentioned

• PF-03084014 (nirogacestat)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Neoplasm, Desmoid Tumor | Status: NO_LONGER_AVAILABLE